Maggi, E., Scambia, G., Fagotti, A., Moretta, L., Pelosi, A., Veneziani, I., . . . Ricci, B. Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset. BMJ Publishing Group.
Chicago Style (17th ed.) CitationMaggi, Enrico, et al. Toll-like Receptor 8 Agonists Improve NK-cell Function Primarily Targeting CD56brightCD16− Subset. BMJ Publishing Group.
MLA (9th ed.) CitationMaggi, Enrico, et al. Toll-like Receptor 8 Agonists Improve NK-cell Function Primarily Targeting CD56brightCD16− Subset. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.